Cargando…
血清多肽组学作为Ⅰ期-Ⅱb期非小细胞肺癌标志物的初步研究
BACKGROUND AND OBJECTIVE: Non-small cell lung cancer (NSCLC) have the highest incidence of lung cancer which treatment principles are diagnosis and treatment as early as possible. Because of its insidious onset and lack of specific markers for early screening, most patients are at an advanced stage...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348161/ https://www.ncbi.nlm.nih.gov/pubmed/30674389 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.01.05 |
Ejemplares similares
-
非小细胞肺癌血清标志物PACAP的蛋白质组学筛选和鉴定
Publicado: (2012) -
CD45RO(+)记忆T细胞作为非小细胞肺癌患者预后标志物的研究
Publicado: (2021) -
应用多肽芯片研究非小细胞肺癌患者血清中的EGFR自身抗体
Publicado: (2010) -
Ⅰ期非小细胞肺癌术后预后的多因素分析
Publicado: (2011) -
联合血清肿瘤标志物建立预测厄洛替尼治疗复治非小细胞肺癌生存模型
Publicado: (2014)